NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,333 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
39,333 Papers indexed
1,440 Papers AI scored
39,333 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-10-16 09:15 AM
1 Ewing Sarcoma PDX Models. Methods in molecular biology (Clifton, N.J.) — Oct 16, 2026 2 Molecular Approaches to Diagnosis in Ewing Sarcoma: RT-PCR. Methods in molecular biology (Clifton, N.J.) — Oct 16, 2026 3 Tissue Preservation and FFPE Samples: Optimized Nucleic Acids Isolation in Ewing Sarcoma. Methods in molecular biology (Clifton, N.J.) — Oct 16, 2026 4 Antibody-mediated encephalitides: distinct diseases with transdisciplinary implications. The Lancet. Neurology — Oct 16, 2026 5 Pediatric prolactinoma-associated pituitary apoplexy presenting with acute visual loss: a case report, literature review, and management strategy. Journal of pediatric endocrinology & metabolism : JPEM — Oct 16, 2026 6 Paediatric bone and soft-tissue sarcomas in Ireland: Epidemiology, management and outcomes. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland — Oct 16, 2026 7 VIRTUAL REALITY-ENHANCED FOR PREOPERATIVE ANATOMICAL ASSESSMENT OF ABDOMINAL NEUROBLASTOMA: A COMPARATIVE STUDY WITH CONVENTIONAL CT IMAGING. Journal of pediatric surgery — Oct 16, 2026 8 Parents' Attributed Gains in Participating in a Telephone-delivered Educational Counseling Program: A Qualitative Study. The American journal of hospice & palliative care — Oct 16, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39333 results
C
Pediatric NTRK-rearranged gliomas: A clinicopathological and molecular analysis of six cases.
PMID 41687475 Published: 2026-02-09 Ingested: 2026-08-02 12:06 AM Pathology, research and practice
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Prognostic Impact of CD57⁺ Natural Killer Cells and CD138⁺ Plasma Cells as Minor Components of the Tumor Microenvironment in Mixed Cellularity Classical Hodgkin Lymphoma.
PMID 41680102 Published: 2026-02-13 Ingested: 2026-08-02 12:06 AM Applied immunohistochemistry & molecular morphology : AIMM
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Lipidomic Signatures in Pediatric Metabolic Disorders.
PMID 41590641 Published: 2025-12-28 Ingested: 2026-08-02 12:05 AM Metabolites
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Recurrent pediatric posterior fossa anaplastic ependymoma managed with multiple resections: illustrative case.
PMID 41569674 Published: 2026-01-19 Ingested: 2026-08-02 12:06 AM Journal of neurosurgery. Case lessons
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Diffuse low-grade glioma with a rare BRAF p.T599dup mutation in a child: importance of clinicopathological and molecular correlation.
PMID 41565923 Published: 2026-01-21 Ingested: 2026-08-02 12:06 AM Brain tumor pathology
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Molecular markers of pediatric cholesteatoma: A gene expression comparison with adult tissue.
PMID 41544404 Published: 2026-01-12 Ingested: 2026-08-02 12:06 AM International journal of pediatric otorhinolaryngology
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Maternal exposure to cyclophosphamide during prepubertal life does not affect the cryosusceptibility of in vitro derived mouse embryos.
PMID 41543016 Published: 2026-01-29 Ingested: 2026-08-02 12:06 AM Reproduction & fertility
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 64.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
PP2A activation targets MYCN in neuroblastoma.
PMID 41539997 Published: 2026-01-15 Ingested: 2026-08-02 12:06 AM Cell death & disease
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
A Primer for Pediatric Plastic Surgeons on Pediatric Head and Neck Malignancies: Part II-The Initial Diagnostic Workup of Common Pediatric Head and Neck Tumors.
PMID 41538782 Published: 2026-04-13 Ingested: 2026-08-02 12:06 AM Annals of plastic surgery
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Establishment and characterization of a testicular yolk sac tumor PDX model.
PMID 41525035 Published: 2026-01-12 Ingested: 2026-08-02 12:06 AM Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 64.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Global, Regional, and National Burden of Hematologic Malignancies From 1990 to 2021, With Projections of Mortality and Incidence to 2031.
PMID 41506717 Published: 2026-01-01 Ingested: 2026-08-02 12:06 AM Psycho-oncology
AI -
Standard 60.8
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.8/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

Previous
Page 1705 of 3278
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic